# Lunai Bioworks Inc.: filings

LNAI · Nasdaq · CIK 1527728 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/lnai.md) · [Financials](/companies/lnai/financials.md) · [Filings](/companies/lnai/filings.md) · [Insiders](/companies/lnai/insiders.md)

## Reports and events: 305 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 172, 4 120, 10-Q 45, 3 38, SC 13D/A 30, UPLOAD 21, DEFA14A 18, CORRESP 16, 10-K 14, DEF 14A 9, 10-K/A 8, 8-K/A 8, NT 10-K 8, 4/A 7, NT 10-Q 7, S-1/A 6, SCHEDULE 13D/A 6, EFFECT 5, 10-Q/A 3, 424B3 3, 424B5 3, 425 3, 5 3, DEFR14A 3, PRE 14A 3, S-3 3, SC 13D 3, 10-12G/A 2, 144 2, D 2, DEF 14C 2, S-3/A 2, S-8 2, S-8 POS 2, SC 13G 2, SC 13G/A 2, SCHEDULE 13G 2, 10-12G 1, 10-KT 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, DEFM14A 1, POS AM 1, PRE 14C 1, PREM14A 1, PRER14A 1, S-1 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 21:38 ET | [8-K](/filings/0001731122-26-001362.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001362 |
| 2026-10-15 | 21:13 ET | [SCHEDULE 13D/A](/filings/0001214659-26-012970.md) | Ownership report, active investor, amended | 0001214659-26-012970 |
| 2026-10-13 | 16:55 ET | [10-K](/filings/0001731122-26-001339.md) | Annual report, period 2026-06-30 | 0001731122-26-001339 |
| 2026-10-09 | 14:00 ET | [8-K](/filings/0001731122-26-001333.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001333 |
| 2026-06-17 | 16:32 ET | [8-K](/filings/0001731122-26-000871.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000871 |
| 2026-06-16 | 16:00 ET | [8-K](/filings/0001731122-26-000865.md) | 8.01 Other events | 0001731122-26-000865 |
| 2026-05-20 | 09:15 ET | [8-K](/filings/0001731122-26-000759.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000759 |
| 2026-05-15 | 16:46 ET | [10-Q](/filings/0001731122-26-000749.md) | Quarterly report, period 2026-03-31 | 0001731122-26-000749 |
| 2026-05-13 | 16:45 ET | [8-K](/filings/0001731122-26-000718.md) | 5.07 Shareholder vote results | 0001731122-26-000718 |
| 2026-05-11 | 17:30 ET | [8-K/A](/filings/0001731122-26-000705.md) | 3.01 Delisting notice | 0001731122-26-000705 |
| 2026-05-01 | 17:17 ET | [8-K](/filings/0001731122-26-000653.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-26-000653 |
| 2026-04-28 | 17:30 ET | [8-K](/filings/0001731122-26-000623.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000623 |
| 2026-04-13 | 17:15 ET | [DEF 14A](/filings/0001731122-26-000559.md) | Proxy statement, period 2026-04-13 | 0001731122-26-000559 |
| 2026-03-30 | 17:35 ET | [8-K](/filings/0001731122-26-000502.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000502 |
| 2026-03-05 | 16:46 ET | [8-K](/filings/0001731122-26-000345.md) | 8.01 Other events | 0001731122-26-000345 |
| 2026-02-23 | 16:33 ET | [8-K](/filings/0001731122-26-000282.md) | 3.01 Delisting notice | 0001731122-26-000282 |
| 2026-02-17 | 15:16 ET | [10-Q](/filings/0001731122-26-000253.md) | Quarterly report, period 2025-12-31 | 0001731122-26-000253 |
| 2026-02-12 | 16:15 ET | [8-K](/filings/0001731122-26-000221.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure | 0001731122-26-000221 |
| 2025-12-09 | 17:43 ET | [SCHEDULE 13D/A](/filings/0001214659-25-017804.md) | Ownership report, active investor, amended | 0001214659-25-017804 |
| 2025-12-03 | 21:31 ET | [8-K](/filings/0001731122-25-001625.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-25-001625 |
| 2025-11-28 | 17:51 ET | [SCHEDULE 13D/A](/filings/0001214659-25-017353.md) | Ownership report, active investor, amended | 0001214659-25-017353 |
| 2025-11-25 | 16:45 ET | [8-K](/filings/0001731122-25-001597.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-25-001597 |
| 2025-11-14 | 16:08 ET | [10-Q](/filings/0001731122-25-001544.md) | Quarterly report, period 2025-09-30 | 0001731122-25-001544 |
| 2025-11-12 | 17:46 ET | [SCHEDULE 13D/A](/filings/0001214659-25-016346.md) | Ownership report, active investor, amended | 0001214659-25-016346 |
| 2025-11-06 | 16:22 ET | [8-K](/filings/0001731122-25-001495.md) | 3.01 Delisting notice | 0001731122-25-001495 |
| 2025-11-03 | 16:31 ET | [8-K](/filings/0001731122-25-001465.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001731122-25-001465 |
| 2025-10-30 | 09:15 ET | [8-K](/filings/0001731122-25-001446.md) | 3.01 Delisting notice | 0001731122-25-001446 |
| 2025-10-16 | 15:21 ET | [8-K](/filings/0001731122-25-001399.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001731122-25-001399 |
| 2025-10-15 | 12:06 ET | [DEF 14A](/filings/0001731122-25-001378.md) | Proxy statement, period 2025-10-15 | 0001731122-25-001378 |
| 2025-09-29 | 15:56 ET | [10-K](/filings/0001731122-25-001316.md) | Annual report, period 2025-06-30 | 0001731122-25-001316 |
| 2025-09-24 | 16:30 ET | [8-K](/filings/0001731122-25-001297.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001297 |
| 2025-09-05 | 17:12 ET | [8-K](/filings/0001731122-25-001204.md) | 2.06 Material impairments; 8.01 Other events | 0001731122-25-001204 |
| 2025-08-26 | 16:45 ET | [8-K](/filings/0001731122-25-001173.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001173 |
| 2025-08-06 | 11:51 ET | [8-K](/filings/0001731122-25-001076.md) | 3.01 Delisting notice | 0001731122-25-001076 |
| 2025-07-30 | 13:08 ET | [DEF 14A](/filings/0001731122-25-001053.md) | Proxy statement, period 2025-07-30 | 0001731122-25-001053 |
| 2025-07-25 | 17:13 ET | [8-K](/filings/0001731122-25-001030.md) | 5.02 Departure or appointment of officers or directors | 0001731122-25-001030 |
| 2025-07-14 | 09:18 ET | [8-K](/filings/0001731122-25-000971.md) | 3.01 Delisting notice | 0001731122-25-000971 |
| 2025-07-10 | 18:45 ET | [SCHEDULE 13D/A](/filings/0001214659-25-010280.md) | Ownership report, active investor, amended | 0001214659-25-010280 |
| 2025-07-09 | 19:43 ET | [8-K](/filings/0001731122-25-000948.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-000948 |
| 2025-06-05 | 16:02 ET | [8-K](/filings/0001731122-25-000829.md) | 5.02 Departure or appointment of officers or directors | 0001731122-25-000829 |
| 2025-05-15 | 16:31 ET | [10-Q](/filings/0001731122-25-000765.md) | Quarterly report, period 2025-03-31 | 0001731122-25-000765 |
| 2025-04-18 | 17:00 ET | [8-K](/filings/0001731122-25-000592.md) | 3.01 Delisting notice | 0001731122-25-000592 |
| 2025-04-14 | 21:46 ET | [SCHEDULE 13D/A](/filings/0001214659-25-005865.md) | Ownership report, active investor, amended | 0001214659-25-005865 |
| 2025-04-10 | 16:55 ET | [8-K](/filings/0001731122-25-000562.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001731122-25-000562 |
| 2025-03-06 | 16:20 ET | [8-K](/filings/0001731122-25-000354.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-25-000354 |
| 2025-02-28 | 16:05 ET | [8-K](/filings/0001731122-25-000312.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-000312 |
| 2025-02-19 | 16:02 ET | [10-Q](/filings/0001731122-25-000258.md) | Quarterly report, period 2024-12-31 | 0001731122-25-000258 |
| 2025-02-19 | 09:00 ET | [10-Q/A](/filings/0001731122-25-000254.md) | Quarterly report, amended, period 2024-09-30 | 0001731122-25-000254 |
| 2025-02-19 | 08:55 ET | [10-K/A](/filings/0001731122-25-000252.md) | Annual report, amended, period 2024-06-30 | 0001731122-25-000252 |
| 2025-02-19 | 08:50 ET | [10-Q/A](/filings/0001731122-25-000250.md) | Quarterly report, amended, period 2024-03-31 | 0001731122-25-000250 |

Page 1 of 7. [Older](/companies/lnai/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 06:04 ET. No prices; not investment advice.